Johnson & Johnson, with support from the Johnson & Johnson Foundation, announced Jan. 27 it has donated $100 million in medtech products since 2020. Building on this effort, the company plans to ...
Johnson & Johnson (NYSE: JNJ) on Wednesday reported a fourth-quarter 2025 adjusted earnings of $2.46 per share, up 20.6% year over year, beating the consensus of $2.44. The pharmaceutical and medtech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results